FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4353092763> ?p ?o ?g. }

• W4353092763 endingPage "629" @default.
• W4353092763 startingPage "629" @default.
• W4353092763 abstract "Background and Objectives: The identification of possible biomarkers that can predict treatment response among DME eyes is important for the individualization of treatment plans. We investigated optical coherence tomography (OCT)-based biomarkers that may predict the one-year real-life outcomes among diabetic macular edema (DME) eyes following treatment by intravitreal ranibizumab (IVR) injections. Materials and Methods: A total of 65 eyes from 35 treatment-naïve patients with DME treated with ranibizumab injection were recruited. Best-corrected visual acuity (BCVA), central retinal thickness (CRT), intraocular pressure (IOP), and OCT scans were retrospectively recorded at baseline before treatment and at 3 months, 6 months, and 12 months after treatment. The OCT scans were evaluated for biomarkers of interest, which included central retinal thickness (CRT), amount and locations of hyperreflective foci (HRF), subretinal fluid (SRF), intraretinal cysts (IRC), large outer nuclear layer cyst (LONLC), ellipsoid zone disruption (EZD), disorganization of retinal inner layers (DRIL), hard exudates (HE), epiretinal membrane (ERM), and vitreomacular interface (VMI). Correlations between these OCT biomarkers and outcome measures (visual and structural) were statistically analyzed. Results: A total of 65 eyes from 35 patients with DME were enrolled. The mean age was 64.2 ± 10.9 years old. Significant improvement in terms of mean BCVA (p < 0.005) and mean CRT was seen at final follow-up compared to baseline. The biomarkers of DRIL, LONLC, and SRF were found to be predictive for at least 50 μm CRT reduction after treatment (with odds ratio of 8.69, 8.5, and 17.58, respectively). The biomarkers of IRC, LONLC, and SRF were predictive for significant improvement in terms of BCVA and CRT after treatment. Finally, the number of HRF was predictive for both BCVA improvement and a CRT reduction of less than 100 μm after treatment. No serious complications were reported during the study. Conclusion: Our study demonstrated the utility of OCT biomarkers as therapeutic predictors of ranibizumab treatment among DME eyes." @default.
• W4353092763 created "2023-03-23" @default.
• W4353092763 creator A5002812282 @default.
• W4353092763 creator A5003323546 @default.
• W4353092763 creator A5008528417 @default.
• W4353092763 creator A5022617419 @default.
• W4353092763 creator A5023210786 @default.
• W4353092763 creator A5044152857 @default.
• W4353092763 creator A5048302255 @default.
• W4353092763 creator A5049912206 @default.
• W4353092763 creator A5062292313 @default.
• W4353092763 creator A5064463285 @default.
• W4353092763 creator A5076227482 @default.
• W4353092763 creator A5082236565 @default.
• W4353092763 date "2023-03-21" @default.
• W4353092763 modified "2023-09-26" @default.
• W4353092763 title "Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections" @default.
• W4353092763 cites W1974420926 @default.
• W4353092763 cites W1982068990 @default.
• W4353092763 cites W1990374749 @default.
• W4353092763 cites W2026044934 @default.
• W4353092763 cites W2027474409 @default.
• W4353092763 cites W2056957024 @default.
• W4353092763 cites W2066516016 @default.
• W4353092763 cites W2079275116 @default.
• W4353092763 cites W2088924190 @default.
• W4353092763 cites W2093666955 @default.
• W4353092763 cites W2102463203 @default.
• W4353092763 cites W2131192872 @default.
• W4353092763 cites W2138480916 @default.
• W4353092763 cites W2161588304 @default.
• W4353092763 cites W2301137133 @default.
• W4353092763 cites W2322106283 @default.
• W4353092763 cites W2536221331 @default.
• W4353092763 cites W2569956386 @default.
• W4353092763 cites W2616361514 @default.
• W4353092763 cites W2748209598 @default.
• W4353092763 cites W2772005413 @default.
• W4353092763 cites W2897439586 @default.
• W4353092763 cites W2899471997 @default.
• W4353092763 cites W2901929903 @default.
• W4353092763 cites W2954675396 @default.
• W4353092763 cites W2963068069 @default.
• W4353092763 cites W2973857794 @default.
• W4353092763 cites W3020972066 @default.
• W4353092763 cites W3036481777 @default.
• W4353092763 cites W3092394797 @default.
• W4353092763 cites W3128311744 @default.
• W4353092763 cites W3204830780 @default.
• W4353092763 cites W3213349080 @default.
• W4353092763 doi "https://doi.org/10.3390/medicina59030629" @default.
• W4353092763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36984630" @default.
• W4353092763 hasPublicationYear "2023" @default.
• W4353092763 type Work @default.
• W4353092763 citedByCount "0" @default.
• W4353092763 crossrefType "journal-article" @default.
• W4353092763 hasAuthorship W4353092763A5002812282 @default.
• W4353092763 hasAuthorship W4353092763A5003323546 @default.
• W4353092763 hasAuthorship W4353092763A5008528417 @default.
• W4353092763 hasAuthorship W4353092763A5022617419 @default.
• W4353092763 hasAuthorship W4353092763A5023210786 @default.
• W4353092763 hasAuthorship W4353092763A5044152857 @default.
• W4353092763 hasAuthorship W4353092763A5048302255 @default.
• W4353092763 hasAuthorship W4353092763A5049912206 @default.
• W4353092763 hasAuthorship W4353092763A5062292313 @default.
• W4353092763 hasAuthorship W4353092763A5064463285 @default.
• W4353092763 hasAuthorship W4353092763A5076227482 @default.
• W4353092763 hasAuthorship W4353092763A5082236565 @default.
• W4353092763 hasBestOaLocation W43530927631 @default.
• W4353092763 hasConcept C118487528 @default.
• W4353092763 hasConcept C134018914 @default.
• W4353092763 hasConcept C141071460 @default.
• W4353092763 hasConcept C2776694085 @default.
• W4353092763 hasConcept C2777802072 @default.
• W4353092763 hasConcept C2778257484 @default.
• W4353092763 hasConcept C2778818243 @default.
• W4353092763 hasConcept C2779829184 @default.
• W4353092763 hasConcept C2780827179 @default.
• W4353092763 hasConcept C2781092963 @default.
• W4353092763 hasConcept C2781100027 @default.
• W4353092763 hasConcept C2781242345 @default.
• W4353092763 hasConcept C2781325737 @default.
• W4353092763 hasConcept C2985127711 @default.
• W4353092763 hasConcept C555293320 @default.
• W4353092763 hasConcept C71924100 @default.
• W4353092763 hasConceptScore W4353092763C118487528 @default.
• W4353092763 hasConceptScore W4353092763C134018914 @default.
• W4353092763 hasConceptScore W4353092763C141071460 @default.
• W4353092763 hasConceptScore W4353092763C2776694085 @default.
• W4353092763 hasConceptScore W4353092763C2777802072 @default.
• W4353092763 hasConceptScore W4353092763C2778257484 @default.
• W4353092763 hasConceptScore W4353092763C2778818243 @default.
• W4353092763 hasConceptScore W4353092763C2779829184 @default.
• W4353092763 hasConceptScore W4353092763C2780827179 @default.
• W4353092763 hasConceptScore W4353092763C2781092963 @default.
• W4353092763 hasConceptScore W4353092763C2781100027 @default.
• W4353092763 hasConceptScore W4353092763C2781242345 @default.
• W4353092763 hasConceptScore W4353092763C2781325737 @default.

• next